Exciting Clinicial Results Presented on Endovascular Hemodialysis Access Technology at LINC 2017

January 26, 2017 - Data from everlinQ endoAVF System: 12-month results, real-world experience, next-generation catheter, and new application for peripheral artery disease all released at LINC 2017.  Read more . . .

TVA Medical Receives $7M in Debt Financing from Square 1 Bank

December 14, 2016 - Square 1 Bank, a division of Pacific Western Bank, today announced that it has provided a $7 million credit facility to new client TVA Medical, Inc.,...Read Full Story

TVA Medical Receives Additional Reimbursement In Germany

February 5, 2016 - TVA Medical, Inc., announced that its everlinQ™ endoAVF System has received NUB Status 1 approval in Germany...Read Full Story

Hemodialysis Access System Demonstrates High Suitability For Dialysis

January 28, 2016 - TVA Medical, Inc., announced primary endpoint data evaluating the everlinQ™ endoAVF System...Read Full Story

Early Study Results Presented for Hemodialysis Access System

November 20, 2015 - TVA Medical, Inc., announced clinical trial results from a study evaluating the everlinQ™ endoAVF System...Read Full Story

TVA Medical Closes $15 Million Series C Financing

October 6, 2015 - TVA Medical, Inc., today announced the completion of a $15 million Series C financing....Read Full Story

FLEX Study Results Published

March 25, 2015 - New Minimally Invasive Vascular Access System Demonstrates Positive Outcomes In Dialysis Patients... Read Full Story

TVA Medical Wins ICI Innovation Award

January 19, 2015 - Austin, Texas — TVA Medical, Inc., today announced it has won the 2014 Innovations in Cardiovascular Interventions (ICI) Best Start-Up Innovation Award... Read Full Story

everlinQ™ Receives CE Mark

September 26, 2014 -

TVA’s FLEX System Demonstrates Success in Clinical Study

September 26, 2013 - Preliminary data presented last week at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting demonstrated... Read Full Story

TVA Receives $9.5M Series B Financing

June 10, 2013 - TVA Medical, Inc. (TVA Medical), a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD), announced today... Read Full Story

TVA Receives $2.6M Series A Financing

January 11, 2010 - Austin-based biomed startup TVA Medical Inc. wrangled $2.6 million Series A funding to spur its minimally-invasive Renal Disease treatment. Read Full Story